Population
Myosin subfragment 1 (S-1)
Design
Preclinical
Authors
Loading...
Nucleotide effects on myosin S1 cleavage remain preclinical; leaves open relevance to cardiac contractility or therapies pending human validation.
Nucleotide binding at the active site of myosin subfragment 1 induces conformational changes that alter its susceptibility to proteolytic cleavage.
Applegate et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: